Q2 2026 · Form 13F Ledger数据来源:SEC EDGAR  
H

HOLDER.TOP

谁持有什么——美股机构持仓的季度账本。
EN · 简 · 繁
机构 / Commodore Capital LP
Form 13F · Q2 2026

Commodore Capital LP

CIK 1831942申报日 2026-08-1413F-HR 在 EDGAR 查看原始申报 ↗
$16.8亿
申报组合市值
33
持仓数量
12
Quarters on record
Top 50
持仓数量

Commodore Capital LP——持仓

共 33 个持仓中的前 33 名,按申报市值排名。股数变动与上一季度对比。
#证券股数股数环比市值占其组合
1RLAY Relay Therapeutics Inc12.0M−29.4%$2.2亿13.4%
2ELVN Enliven Therapeutics Inc3.3M+0.0%$1.7亿9.9%
3ALKS Alkermes Plc3.0M−28.6%$1.6亿9.4%
4COGT Cogent Biosciences Inc3.0M+5.6%$1.2亿7.0%
5AMLX Amylyx Pharmaceuticals Inc5.7M+0.0%$1.0亿6.0%
6DFTX Definium Therapeutics Inc2.0M+0.0%$9408万5.6%
7SYRE Spyre Therapeutics Inc846,786−55.7%$7518万4.5%
8ANRO Alto Neuroscience Inc2.7M+0.0%$7187万4.3%
9TNGX Tango Therapeutics Inc2.2M—$7034万4.2%
10EYPT Eyepoint Inc4.6M+62.8%$6578万3.9%
11TYRA Tyra Biosciences Inc1.9M−24.2%$5989万3.6%
12DMRA Damora Therapeutics Inc1.9M+0.0%$5043万3.0%
13CLDX Celldex Therapeutics Inc New1.4M−49.9%$5023万3.0%
14PHVS Pharvaris N V1.4M−25.7%$4928万2.9%
15LBRX Lb Pharmaceuticals Inc1.5M+0.0%$4868万2.9%
16ASMB Assembly Biosciences Inc1.4M+41.5%$3888万2.3%
17EDIT Editas Medicine Inc8.9M—$2880万1.7%
18KYMR Kymera Therapeutics Inc250,000−66.7%$2867万1.7%
19CATX Perspective Therapeutics Inc6.3M+0.0%$2161万1.3%
20IPSC Century Therapeutics Inc8.7M+0.0%$2130万1.3%
21ZURA Zura Bio Ltd3.2M+0.0%$1918万1.1%
22AVTX Avalo Therapeutics Inc1.0M+110.8%$1882万1.1%
23IFRX Inflarx Nv7.3M—$1635万1.0%
24ANTX An2 Therapeutics Inc2.9M+25.7%$1420万0.8%
25NUVALENT INC Nuvalent Inc100,000−88.0%$1235万0.7%
26SABS Sab Biotherapeutics Inc2.9M−34.8%$1119万0.7%
27IKT Inhibikase Therapeutics Inc5.4M+0.0%$1096万0.7%
28RLMD Relmada Therapeutics Inc1.4M+124.8%$986万0.6%
29PEPG Pepgen Inc4.5M+0.0%$806万0.5%
30RACC Research Alliance Corp Iii500,000—$535万0.3%
31HLXC Helix Acquisition Corp Iii500,000+0.0%$532万0.3%
32LONA Leonabio Inc464,398+0.0%$427万0.3%
33VTGN Vistagen Therapeutics Inc2.8M—$63万0.0%
来源:经 SEC EDGAR 的 Form 13F 申报。持仓截至 2026 年 6 月 30 日。期权(看涨/看跌)不计入股数。